- Research works
- 23 ▼ 54% vs 2013–17
- Citations
- 421 18.4 per fractional work
- Top-10% rate
- 23.4% record average 16.5%
- Open access
- 35% world 28%
Not ranked overall: ARCA Biopharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 2.9×. Every wedge is a field page.
Which keywords describe research at ARCA Biopharma (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cardiovascular Disease, Chronic Kidney Disease, Heart Failure, Renal Function, Guidelines, Treatment, Fibrosis and Diagnosis.
- Global Burden
- Cardiovascular Risk
- Renal Failure
- Long-QT Syndrome
- G-Protein-Coupled Receptors
- Cardiac Electrophysiology
- Genetic Testing
- Arrhythmias
- Cell Signaling
- Metabolic Syndrome
- B-Type Natriuretic Peptide
- Diagnosis
- Guidelines
- Epidemiology
- Chronic Kidney Disease
- Cardiovascular Disease
- Heart Failure
- Renal Function
- Treatment
- Fibrosis
- Hospital Readmission
- Calcium Signaling
- Inflammation
- Biomarkers
- Acute Kidney Injury
- Crystal Structure
- Ion Channels
- Oxidative Stress
- Sudden Cardiac Death
- Diabetic Nephropathy
- Glomerular Filtration Rate
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 31 words, with their numbers
- Cardiovascular Disease3▲ 13×8 topics
- Chronic Kidney Disease3▲ 57×4 topics
- Heart Failure3▲ 30×8 topics
- Epidemiology3▲ 2.8×7 topics
- Renal Function2▲ 93×3 topics
- Guidelines2▲ 20×5 topics
- Treatment2▲ 7.1×4 topics
- Diagnosis2▲ 7.8×4 topics
- Fibrosis2▲ 41×4 topics
- B-Type Natriuretic Peptide2▲ 150×1 topic
- Hospital Readmission2▲ 150×1 topic
- Metabolic Syndrome2▲ 7.6×5 topics
- Calcium Signaling1▲ 47×3 topics
- Cell Signaling1▲ 18×3 topics
- Inflammation1▲ 2.6×9 topics
- Arrhythmias1▲ 43×2 topics
- Biomarkers1▲ 9.4×2 topics
- Genetic Testing1▲ 36×2 topics
- Acute Kidney Injury1▲ 103×1 topic
- Cardiac Electrophysiology1▲ 69×1 topic
- Crystal Structure1▲ 21×1 topic
- G-Protein-Coupled Receptors1▲ 65×1 topic
- Ion Channels1▲ 25×2 topics
- Long-QT Syndrome1▲ 69×1 topic
- Oxidative Stress1▲ 2.9×7 topics
- Renal Failure1▲ 118×1 topic
- Sudden Cardiac Death1▲ 45×2 topics
- Cardiovascular Risk1▲ 13×2 topics
- Diabetic Nephropathy1▲ 69×1 topic
- Global Burden1▲ 9.0×2 topics
- Glomerular Filtration Rate1▲ 144×1 topic
Which research topics does ARCA Biopharma (United States) publish most on?
By volume in 2022–2025: Viral Infections and Immunology Research, Cardiac electrophysiology and arrhythmias, Mining Techniques and Economics and SARS-CoV-2 and COVID-19 Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 0 works
- 2 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 0 works
- 3 Mining Techniques and Economics Control and Systems Engineering 0 works
- 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 5 Minerals Flotation and Separation Techniques Water Science and Technology 0 works
- 6 Mineral Processing and Grinding Mechanical Engineering 0 works
- 7 Tailings Management and Properties Civil and Structural Engineering 0 works
- 8 Chronic Kidney Disease and Diabetes Nephrology 0 works
- 9 Renin-Angiotensin System Studies Cardiology and Cardiovascular Medicine 0 works
- 10 Medical and Biological Ozone Research Pharmacology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has ARCA Biopharma (United States)'s research output changed?
Output in 2018–2022 was 54% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Westminster
- Maxar Technologies (United States)
- Front Range Community College
- QuSpin (United States)
- DigitalGlobe Foundation
- Weed Science Society of America
- Keystone Tower Systems (United States)
- Colorado Foundation for Agriculture
- AlphaTRAC (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.